G9052
HCPCSOnc surveillance for disease
Official HCPCS Level II long descriptor
Oncology; primary focus of visit; surveillance for disease recurrence for patient who has completed definitive cancer-directed therapy and currently lacks evidence of recurrent disease; cancer directed therapy might be considered in the future (for use in a medicare-approved demonstration project)
HCPCS Level II code G9052 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Onc surveillance for disease
Added to HCPCS: 2006-01-01
Nearby codes in G9
- G9010Mccd, risk adj, level 4
- G9011Mccd, risk adj, level 5
- G9012Other specified case mgmt
- G9013Esrd demo bundle level i
- G9014Esrd demo bundle-level ii
- G9016Demo-smoking cessation coun
- G9050Oncology work-up evaluation
- G9051Oncology tx decision-mgmt
- G9053Onc expectant management pt
- G9054Onc supervision palliative
- G9055Onc visit unspecified nos
- G9056Onc prac mgmt adheres guide
- G9057Onc pract mgmt differs trial
- G9058Onc prac mgmt disagree w/gui
- G9059Onc prac mgmt pt opt alterna
- G9060Onc prac mgmt dif pt comorb
Where this code sits
Krasyn Codes for Chrome
Review coding suggestions beside a validated web workflow. Private pilot.
Request pilot accessSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.